Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

INVANZ DIN 02247437

Status: Marketed
Holder: MERCK CANADA INC
Molecule: ERTAPENEM (ERTAPENEM SODIUM)
Available to quote

Health Canada record

Active ingredient(s)ERTAPENEM (ERTAPENEM SODIUM) 1 G
Dosage formPowder For Solution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01DH03 ERTAPENEM
Original market date27-Aug-2003
Current status date06-Jul-2006
SourceHealth Canada DPD

Establishment licence of the holder

Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ERTAPENEM (ERTAPENEM SODIUM)

DINProductCompanyFormStrengthStatus
02490773ERTAPENEM FOR INJECTIONJUNO PHARMA CANADA INC.Powder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02492148ERTAPENEM FOR INJECTIONAURO PHARMA INCPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02496127ERTAPENEM FOR INJECTIONFRESENIUS KABI CANADA LTDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02505126ERTAPENEM FOR INJECTIONHIKMA CANADA LIMITEDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GApproved
02511150ERTAPENEM FOR INJECTIONDR REDDY'S LABORATORIES LTDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02537176ERTAPENEM FOR INJECTIONEUGIA PHARMA INC.Powder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02539500ERTAPENEM FOR INJECTIONOMEGA LABORATORIES LIMITEDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GCancelled Pre Market
02539799ERTAPENEM FOR INJECTIONMANTRA PHARMA INCPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
69932005-06-02New Drug Submission (NDS)MANUFACTURER NAME CHANGE
6262003-05-12New Drug Submission (NDS)
Request a quote for INVANZ

How to read a Canadian DIN record